LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 140 pages found matching zyprexa- American Kids Being Drugged To Death
Aug-22-07 Washington, DC: As result of the marketing power the pharmaceutical industry obtained by spending tens of billions of dollars to gain influence over politicians in power, the FDA and the medical profession, American kids are being pumped full of the most powerful and dangerous psychiatric medications on the market, in drug cocktails that are literally kill... - Biggest Off-Label Drug Marketing Scheme in US History - Part I
Nov-30-06 Washington, DC: The promotion and sale of two classes of psychiatric drugs, the atypical antipsychotics and selective serotonin reuptake inhibitors antidepressants (SSRIs), will go down in history as the most successful off-label marketing scheme of all time. But unfortunately, before the illegal scheme takes its rightful place in the law books, a lot m... - Drug Marketing Scheme Hits Nation's School System
Jan-26-06 TeenScreen, the elaborate drug marketing scheme concocted by the pharmaceutical industry and a front group operating out of Columbia University, is being promoted by the Bush administration's recommendation to screen the nation's school population for mental illness. The Bush appointed New Freedoms Commission on Mental Health issued a report in July 2003... - “A Long 10 Years for Risperdal Payout,” Says Whistleblower’s Attorney
Nov-13-13 New Brunswick, NJ While the payout to Johnson & Johnson Risperdal whistleblowers is one of the biggest awards ever, attorney Gary Farmer - whose client was one of the Risperdal whistleblowers - says it is not much more than a slap on the wrist for the giant drug company. Janssen Pharmaceuticals, a pharmaceutical company of J&J, will pay the fe... - A Potential New Market for Byetta?
Aug-18-10 Cincinatti, OH Type 2 diabetes drug Byetta , thought to be associated with acute pancreatitis and various other side effects, may one day put at risk an even wider range of patients. That's because an injectable form of Byetta is being considered for the treatment of a side effect caused by another drug. Zyprexa (olanzapine), a drug used to treat bi... - Whistleblowers Reveal Over-Medicating For Profit
Feb-19-06 In Pennsylvania, whistleblower, Dr Kruszewski, discovered cases where adults and children in state care were prescribed as many as 5 psychiatric drugs at the same time. When he went to his superiors to report the over-prescribing and warned of the potential liability to the state if it was allowed to continue, he was told "it is none of your business." A... - Abilify & Aripiprazole Lawsuit Information and Legal News
Abilify (known generically as aripiprazole ) is in a class of drugs called atypical antipsychotics and is used to treat schizophrenia. Abilify side effects reportedly include an increased risk of diabetes and other blood sugar disorders, including hyperglycemia. A recent product liability and personal injury lawsuit filed against Abilify manufacturers c... - Efectos Secundarios de Risperdal
Risperdal (risperidona nombre genérico) es un antipsicótico atípico que actúa cambiando la actividad de ciertas sustancias naturales en el cerebro. Desarrollado por Janssen Pharmaceuticals, una filial de Johnson & Johnson, Risperdal fue aprobado por la FDA en 1993 para el tratamiento de la esquizofrenia en adultos. Sin embargo demandas por Risperdal han... - Risperdal FAQ
What are common Risperdal side effects? Side effects include nausea, dizziness, anxiety, low blood pressure, insomnia, muscle pain and stiffness, sedation, weight gain, tremors, sexual dysfunction, male breast growth, and sometimes lactation in both males and females. Who is prescribed Risperdal? Risperdal (generic version: risperidone)... - Risperdal Lawsuit News and Legal Information
Risperda l (generic name Risperidone) is an atypical antipsychotic that works by changing the activity of certain natural substances in the brain. Developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, Risperdal was approved by the FDA in 1993 for the treatment of schizophrenia in adults. Risperdal Lawsuits have shown a link between... - Canadian Study Finds 12 Percent of ADHD Youth Prescribed Antipsychotic Drugs Such as Risperdal
Feb-10-17 Toronto, ON: A recent Canadian study found that nearly 12 percent of Ontario youth diagnosed with attention deficit hyperactivity disorder (ADHD) are prescribed antipsychotic drugs such as Risperdal (Risperidone) , Zyprexa and Seroquel despite having no other mental health diagnoses. The study by the Institute for Clinical Evaluative Sciences (ICES)... - Attorneys and Victims Undeterred by Recent Actos Verdict
May-16-13 New York, NY The judge in the nation’s first Actos trial, which resulted in a $6.5 million verdict against the Actos manufacturer Takeda, has granted the company’s request to nullify the verdict. But Actos attorneys and Actos bladder cancer victims remain optimistic - because the jury first found for the plaintiff, they believe it paved the... - J&J Agrees $158M Settlement in Risperdal Lawsuit
New York, NY: Johnson & Johnson (J&J) has agreed to pay $158 million to settle a lawsuit in Texas suit that alleges the company defrauded the state by misleading doctors about its antipsychotic drug Risperdal. The deal will reportedly bring an end to claims that J&J marketed Risperdal off label - for unapproved uses - and downplayed... - GSK To Pay $3 Billion to Settle Avandia Claims
Nov-3-11 Washington, DC A $3 billion settlement has been reached between GlaxoSmithKline, the maker of the controversial diabetes medication Avandia, and federal authorities, ending investigations into whether or not the company marketed drugs for unapproved uses, among other charges. According to media reports, the GSK settlement tops the $2.3 million paid... - Psychiatric Drugging of Children Intolerable--Part 1
Feb-19-09 Washington, DC: Last September, the Law Project for Psychiatric Rights filed what is sure to become a landmark case against the State of Alaska aimed at stopping the over-prescribing of psychiatric drugs to children covered by public health care programs in that state. "The massive over-drugging of America's youth is an unfolding national horror," sa... - Daniel Troy - Bush Administration's Preemption Gang - Part II
Feb-26-08 Washington, DC: In the fall of 2004, Daniel Troy left the FDA armed with the preemption policy he put in place. Now a partner at Sidley Austin Brown & Wood, Mr Troy works for a firm that he told Lily Henning of the Legal Times on September 20, 2005, "represents pretty much almost every company" in the brand-name drug industry. In fact, Sidley Austin i... - World Experts Demand End to Child Drugging in the US - Part II
Oct-27-07 Washington, DC: Mathy Milling Downing was a featured speaker at the annual conference of the International Center for the Study of Psychiatry and Psychology and told the audience that her anger is directed toward the FDA and drug companies, "for their incompetence and lack of concern for innocent children they have helped to kill, my little girl included."... - It's Time To Sue Doctors Who Prescribe Drugs Off-Label Part I
Aug-15-07 Washington, DC: Critics say the tens of thousands of lawsuits filed against the drug giants have had little impact when it comes to dismantling the off-label drug marketing schemes and therefore, there needs to be an all out campaign of highly publicized lawsuits filed against the doctors serving as middle man pushers, one by one by one. It is illegal... - Lawmakers Want to End Big Pharma Recruitment Schemes - Part 2
May-30-07 Washington, DC: The whole idea of mining for psychiatric drug customers by screening all Americans for mental health disorders came to fruition as the result of the campaign contributions by the pharmaceutical industry, which in large part helped George W Bush take up residence in the White House. To repay his enormous debt to the industry, on April 29,... - Biggest Off-Label Drug Marketing Scheme in History - Part II
Dec-1-06 [ Read Part I ] Washington DC: In fairness to off-label prescribing doctors, until recently, studies that showed SSRIs were ineffective and dangerous when used by children were kept hidden and thus, the data made available to physicians painted a rosy, but false, picture of success with SSRIs. And up until recently, many doctors were not even awar...